HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dagmar Kubitza Selected Research

Fontan Procedure (Fontan Operation)

1/2022Dosing Regimen Prediction and Confirmation With Rivaroxaban for Thromboprophylaxis in Children After the Fontan Procedure: Insights From the Phase III UNIVERSE Study.
1/2022Model-informed bridging of rivaroxaban doses for thromboprophylaxis in pediatric patients aged 9 years and older with congenital heart disease.
10/2021Population pharmacokinetic analysis of rivaroxaban in children and comparison to prospective physiologically-based pharmacokinetic predictions.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Dagmar Kubitza Research Topics

Disease

18Venous Thromboembolism
11/2022 - 08/2006
15Hemorrhage
02/2024 - 10/2005
8Thrombosis (Thrombus)
01/2022 - 03/2010
5Body Weight (Weight, Body)
01/2022 - 02/2007
3Venous Thrombosis (Deep-Vein Thrombosis)
12/2020 - 10/2018
3Stroke (Strokes)
01/2018 - 08/2006
3Atrial Fibrillation
01/2018 - 08/2006
2Neoplasms (Cancer)
11/2022 - 10/2018
2Congenital Heart Defects (Congenital Heart Defect)
01/2022 - 10/2021
2Acute Coronary Syndrome
07/2016 - 02/2012
1Renal Insufficiency (Renal Failure)
02/2024
1Thrombocytopenia (Thrombopenia)
11/2022
1Frailty
10/2018
1Pulmonary Embolism
10/2018
1Hemorrhagic Stroke
01/2018
1Embolism (Embolus)
07/2016
1Breast Neoplasms (Breast Cancer)
09/2013
1Bacterial Infections (Bacterial Infection)
01/2010
1Pelvic Inflammatory Disease (Pelvic Inflammatory Diseases)
08/2008
1Abdominal Abscess
01/2008
1Abscess
01/2008
1Diabetes Mellitus
01/2004

Drug/Important Bio-Agent (IBA)

24RivaroxabanIBA
11/2022 - 10/2005
9AnticoagulantsIBA
11/2022 - 02/2007
4Vitamin KFDA Link
01/2020 - 01/2014
4Moxifloxacin (Avelox)FDA Link
01/2010 - 01/2004
3Enoxaparin (Lovenox)FDA LinkGeneric
09/2016 - 03/2010
2Fondaparinux (Arixtra)FDA Link
10/2019 - 08/2006
2Cytochrome P-450 CYP3AIBA
10/2018 - 09/2013
2Member 1 Subfamily B ATP Binding Cassette TransporterIBA
10/2018 - 09/2013
2Warfarin (Coumadin)FDA LinkGeneric
01/2018 - 02/2012
2Factor Xa InhibitorsIBA
07/2016 - 08/2013
2Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
08/2013 - 02/2012
1osocimabIBA
02/2024
1TabletsIBA
01/2020
1Heparin (Liquaemin)FDA LinkGeneric
01/2020
1SuspensionsIBA
01/2020
1Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
10/2019
1N(4)-oleylcytosine arabinosideIBA
01/2018
1Biomarkers (Surrogate Marker)IBA
07/2016
1Cytochrome P-450 CYP2J2 (CYP2J2)IBA
09/2013
1Proteins (Proteins, Gene)FDA Link
09/2013
1fibrin fragment D (D-dimer)IBA
08/2013
1Prothrombin (Factor II)IBA
07/2013
1ThrombinFDA Link
07/2013
1Fibrinogen (Factor I)FDA Link
07/2013
1FibrinIBA
07/2013
1Factor Xa (Coagulation Factor Xa)IBA
07/2013
1Clopidogrel (Plavix)FDA Link
02/2012
1thienopyridineIBA
02/2012
1FluoroquinolonesIBA
01/2008
1Anti-Infective Agents (Microbicides)IBA
01/2008
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
04/2007
1idraparinuxIBA
08/2006
1Glucose (Dextrose)FDA LinkGeneric
01/2004

Therapy/Procedure

7Therapeutics
11/2022 - 01/2008
4Catheters
10/2020 - 01/2018
3Fontan Procedure (Fontan Operation)
01/2022 - 10/2021
2Central Venous Catheters
10/2020 - 01/2018
2Secondary Prevention
07/2016 - 02/2012
1Renal Dialysis (Hemodialysis)
02/2024
1Contraindications
01/2018
1Knee Replacement Arthroplasty (Total Knee Replacement)
03/2010
1Bone Marrow Transplantation (Transplantation, Bone Marrow)
01/2010
1Intravenous Infusions
01/2008
1Orthopedic Procedures
07/2007